These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28051075)

  • 21. Bietti crystalline corneoretinal dystrophy associated with CYP4V2 gene mutations.
    Nakamura M; Lin J; Nishiguchi K; Kondo M; Sugita J; Miyake Y
    Adv Exp Med Biol; 2006; 572():49-53. PubMed ID: 17249554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotype and Long-term Clinical Course of Bietti Crystalline Dystrophy in Korean and Japanese Patients.
    Murakami Y; Koyanagi Y; Fukushima M; Yoshimura M; Fujiwara K; Akiyama M; Momozawa Y; Ueno S; Terasaki H; Oishi A; Miyata M; Ikeda H; Tsujikawa A; Mizobuchi K; Hayashi T; Fujinami K; Tsunoda K; Park JY; Han J; Kim M; Lee CS; Kim SJ; Park TK; Joo K; Woo SJ; Ikeda Y; Sonoda KH
    Ophthalmol Retina; 2021 Dec; 5(12):1269-1279. PubMed ID: 33636399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CHOROIDAL AND RETINAL ATROPHY OF BIETTI CRYSTALLINE DYSTROPHY PATIENTS WITH CYP4V2 MUTATIONS COMPARED TO RETINITIS PIGMENTOSA PATIENTS WITH EYS MUTATIONS.
    Miyata M; Hata M; Ooto S; Ogino K; Gotoh N; Morooka S; Hasegawa T; Hirashima T; Sugahara M; Kuroda Y; Yamashiro K; Yoshimura N
    Retina; 2017 Jun; 37(6):1193-1202. PubMed ID: 27658286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of a human induced pluripotent stem cell line from a Bietti crystalline corneoretinal dystrophy patient with CYP4V2 mutations.
    Wu S; Zhu T; Sun Z; Wei X; Han X; Zou X; Sui R
    Stem Cell Res; 2021 May; 53():102330. PubMed ID: 33857831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of corneal crystals confirms an unusual presentation of Bietti's retinal dystrophy.
    Song WK; Clouston P; MacLaren RE
    Ophthalmic Genet; 2019 Oct; 40(5):461-465. PubMed ID: 31638456
    [No Abstract]   [Full Text] [Related]  

  • 26. [Progress in the studies of molecular genetics in Bietti crystalline corneoretinal dystrophy].
    Xu F; Sui RF; Dong FT
    Zhonghua Yan Ke Za Zhi; 2012 Oct; 48(10):948-51. PubMed ID: 23302251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel CYP4V2 gene mutation in a Mexican patient with Bietti's crystalline corneoretinal dystrophy.
    Zenteno JC; Ayala-Ramirez R; Graue-Wiechers F
    Curr Eye Res; 2008 Apr; 33(4):313-8. PubMed ID: 18398705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystals deposits in the anterior and posterior lens cortex in Bietti corneo-retinal dystrophy.
    Louati Y; Vaclavik V; Moulin A; Schorderet D; Munier FL; Viet Tran H
    Ophthalmic Genet; 2021 Dec; 42(6):773-779. PubMed ID: 34310258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotype-phenotype analysis of Bietti crystalline dystrophy in a family with the CYP4V2 Ile111Thr mutation.
    García-García GP; López-Garrido MP; Martínez-Rubio M; Moya-Moya MA; Belmonte-Martínez J; Escribano J
    Cornea; 2013 Jul; 32(7):1002-8. PubMed ID: 23538635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimodal imaging features and genetic findings in Bietti crystalline dystrophy.
    Wang W; Chen W; Bai X; Chen L
    BMC Ophthalmol; 2020 Aug; 20(1):331. PubMed ID: 32799831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detailed functional and structural phenotype of Bietti crystalline dystrophy associated with mutations in CYP4V2 complicated by choroidal neovascularization.
    Fuerst NM; Serrano L; Han G; Morgan JI; Maguire AM; Leroy BP; Kim BJ; Aleman TS
    Ophthalmic Genet; 2016 Dec; 37(4):445-452. PubMed ID: 27028354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Choroidal Vasculature in Bietti Crystalline Dystrophy With CYP4V2 Mutations and in Retinitis Pigmentosa With EYS Mutations.
    Hirashima T; Miyata M; Ishihara K; Hasegawa T; Sugahara M; Ogino K; Yoshikawa M; Hata M; Kuroda Y; Muraoka Y; Ooto S; Yoshimura N
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):3871-3878. PubMed ID: 28763560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and genetic features in Italian Bietti crystalline dystrophy patients.
    Rossi S; Testa F; Li A; Yaylacioğlu F; Gesualdo C; Hejtmancik JF; Simonelli F
    Br J Ophthalmol; 2013 Feb; 97(2):174-9. PubMed ID: 23221965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bietti Crystalline Retinopathy Confirmed by Mutation of CYP4V2 Gene in a Korean Patient.
    Park YJ; Hwang DJ; Seong MW; Park SS; Woo SJ
    Korean J Ophthalmol; 2016 Feb; 30(1):81-3. PubMed ID: 26865810
    [No Abstract]   [Full Text] [Related]  

  • 35. Expanding the Phenotypic and Genotypic Spectrum of Bietti Crystalline Dystrophy.
    da Palma MM; Motta FL; Salles MV; Texeira CHM; Gomes AV; Casaroli-Marano R; Sallum JMF
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34068831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2.
    Li A; Jiao X; Munier FL; Schorderet DF; Yao W; Iwata F; Hayakawa M; Kanai A; Shy Chen M; Alan Lewis R; Heckenlively J; Weleber RG; Traboulsi EI; Zhang Q; Xiao X; Kaiser-Kupfer M; Sergeev YV; Hejtmancik JF
    Am J Hum Genet; 2004 May; 74(5):817-26. PubMed ID: 15042513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal deposits on the lens capsules in Bietti crystalline corneoretinal dystrophy associated with a mutation in the CYP4V2 gene.
    Yokoi Y; Nakazawa M; Mizukoshi S; Sato K; Usui T; Takeuchi K
    Acta Ophthalmol; 2010 Aug; 88(5):607-9. PubMed ID: 19508456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uncovering the role of ferroptosis in Bietti crystalline dystrophy and potential therapeutic strategies.
    Shen C; Yang Q; Chen K; Ma H; Wang X; Tong J; Shen Y; Cui H
    Cell Commun Signal; 2024 Jul; 22(1):359. PubMed ID: 38992691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetics of Bietti Crystalline Dystrophy.
    Ng DS; Lai TY; Ng TK; Pang CP
    Asia Pac J Ophthalmol (Phila); 2016; 5(4):245-52. PubMed ID: 27228076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AAV2-mediated gene therapy for Bietti crystalline dystrophy provides functional CYP4V2 in multiple relevant cell models.
    Wang JH; Lidgerwood GE; Daniszewski M; Hu ML; Roberts GE; Wong RCB; Hung SSC; McClements ME; Hewitt AW; Pébay A; Hickey DG; Edwards TL
    Sci Rep; 2022 Jun; 12(1):9525. PubMed ID: 35680963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.